+1-518-618-1030 866 - 552 - 3453 USA-Canada Toll Free
Published Date: 2017-07-13Number of Pages: 187

Oligonucleotide Synthesis Market (Product - Reagents & Consumables, Equipment, and Synthesized Oligonucleotides (DNA Oligonucleotides and RNA Oligonucleotides); Application - Research (Polymerase Chain Reaction and Next Generation Sequencing), Therapeutics (Antisense Oligonucleotides, and Nucleic Acid Aptamers), and Diagnostics; End User - Biotechnology & Pharmaceutical Companies, Research Institutes, and Diagnostic Laboratories) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 - 2025

1. Preface
     1.1. Market Definition and Scope
     1.2. Market Segmentation
     1.3. Key Research Objectives
     1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Oligonucleotide Synthesis Market

4. Market Overview
     4.1. Introduction
            4.1.1. Product Type Definition
            4.1.2. Industry Evolution / Developments
     4.2. Overview
     4.3. Key Market Indicators
     4.4. Market Dynamics
            4.4.1. Drivers
            4.4.2. Restraints
            4.4.3. Opportunity
     4.5. Global Oligonucleotide Synthesis Market Analysis and Forecasts, 2015–2025
            4.5.1. Market Revenue Projections (US$ Mn)
     4.6. Oligonucleotide Synthesis Market - Global Supply Demand Scenario
     4.7. Porter’s Five Force Analysis
     4.8. Value Chain Analysis
     4.9. Market Outlook
     4.10. Applications of Oligonucleotides
     4.11. PEST Analysis
     4.12. Pipeline Analysis

5. Global Oligonucleotide Synthesis Market Analysis and Forecasts, By Product Type 
     5.1. Introduction & Definition
     5.2. Key Findings / Developments
     5.3. Key Trends
     5.4. Market Value Forecast by Product Type, 2015–2025
            5.4.1. Reagents & Consumables
            5.4.2. Equipment
            5.4.3. Synthesized oligonucleotides
                     5.4.3.1. DNA Oligonucleotides  
                     5.4.3.2. RNA Oligonucleotides 
                     5.4.3.3. Others
     5.5. Market Attractiveness by Product Type 

6. Global Oligonucleotide Synthesis Market Analysis and Forecasts, By Application 
     6.1. Introduction & Definition
     6.2. Key Findings / Developments
     6.3. Key Trends
     6.4. Market Value Forecast by Application, 2015–2025
            6.4.1. Research
                     6.4.1.1. Polymerase Chain Reaction 
                     6.4.1.2. Next Generation Sequencing 
                     6.4.1.3. Others
            6.4.2. Therapeutics 
                     6.4.2.1. Antisense Oligonucleotides
                     6.4.2.2. Nucleic Acid Aptamers
            6.4.3. Diagnostics
     6.5. Market Attractiveness by Application 

7. Global Oligonucleotide Synthesis Market Analysis and Forecasts, By End User 
     7.1. Introduction & Definition
     7.2. Key Findings / Developments
     7.3. Key Trends
     7.4. Market Value Forecast by End User, 2015–2025
            7.4.1. Biotechnology & Pharmaceutical Companies 
            7.4.2. Research Institutes  
            7.4.3. Diagnostic Laboratories 
     7.5. Market Attractiveness by End User 

8. Global Oligonucleotide Synthesis Market Analysis and Forecasts, By Region
     8.1. Key Findings
     8.2. Policies and Regulations
     8.3. Market Value Forecast by Region
            8.3.1. North America 
            8.3.2. Europe             
            8.3.3. Asia Pacific  
            8.3.4. Latin America  
            8.3.5. Middle East & Africa 
     8.4. Market Attractiveness by Country/Region

9. North America Oligonucleotide Synthesis Market Analysis and Forecast
     9.1. Introduction
            9.1.1. Key Findings
            9.1.2. Key Trends
     9.2. Market Value Forecast by Product Type, 2015–2025
            9.2.1. Reagents & Consumables
            9.2.2. Equipment
            9.2.3. Synthesized oligonucleotides
                     9.2.3.1. DNA Oligonucleotides  
                     9.2.3.2. RNA Oligonucleotides 
                     9.2.3.3. Others
     9.3. Market Value Forecast by Application, 2015–2025
            9.3.1. Research 
                     9.3.1.1. Polymerase Chain Reaction 
                     9.3.1.2. Next Generation Sequencing 
                     9.3.1.3. Others
            9.3.2. Therapeutics             
                     9.3.2.1. Antisense Oligonucleotides
                     9.3.2.2. Nucleic Acid Aptamers
            9.3.3. Diagnostics
     9.4. Market Value Forecast by End User, 2015–2025
            9.4.1. Biotechnology & Pharmaceutical Companies 
            9.4.2. Research Institutes  
            9.4.3. Diagnostic Laboratories 
     9.5. Market Value Forecast by Country, 2015–2025
            9.5.1. U.S.
            9.5.2. Canada
     9.6. Market Attractiveness Analysis 
            9.6.1. By Product Type 
            9.6.2. By Application 
            9.6.3. By End User 
            9.6.4. By Country

10. Europe Oligonucleotide Synthesis Market Analysis and Forecast
     10.1. Introduction
            10.1.1. Key Findings
            10.1.2. Key Trends
     10.2. Market Value Forecast by Product Type, 2015–2025
            10.2.1. Reagents & Consumables
            10.2.2. Equipment
            10.2.3. Synthesized oligonucleotides
                     10.2.3.1. DNA Oligonucleotides  
                     10.2.3.2. RNA Oligonucleotides 
                     10.2.3.3. Others
     10.3. Market Value Forecast by Application, 2015–2025
            10.3.1. Research 
                     10.3.1.1. Polymerase Chain Reaction 
                     10.3.1.2. Next Generation Sequencing 
                     10.3.1.3. Others
            10.3.2. Therapeutics 
                     10.3.2.1. Antisense Oligonucleotides
                     10.3.2.2. Nucleic Acid Aptamers
            10.3.3. Diagnostics
     10.4. Market Value Forecast by End User, 2015–2025
            10.4.1. Biotechnology & Pharmaceutical Companies 
            10.4.2. Research Institutes  
            10.4.3. Diagnostic Laboratories 
     10.5. Market Value Forecast by Country, 2015–2025
            10.5.1. Germany
            10.5.2. U.K.
            10.5.3. France
            10.5.4. Italy 
            10.5.5. Spain 
            10.5.6. Rest of Europe
     10.6. Market Attractiveness Analysis 
            10.6.1. By Product Type 
            10.6.2. By Application 
            10.6.3. By End User 
            10.6.4. By Country

11. Asia Pacific Oligonucleotide Synthesis Market Analysis and Forecast
     11.1. Introduction
            11.1.1. Key Findings
            11.1.2. Key Trends
     11.2. Market Value Forecast by Product Type, 2015–2025
            11.2.1. Reagents & Consumables
            11.2.2. Equipment
            11.2.3. Synthesized oligonucleotides
                     11.2.3.1. DNA Oligonucleotides  
                     11.2.3.2. RNA Oligonucleotides 
                     11.2.3.3. Others
     11.3. Market Value Forecast by Application, 2015–2025
            11.3.1. Research 
                     11.3.1.1. Polymerase Chain Reaction 
                     11.3.1.2. Next Generation Sequencing 
                     11.3.1.3. Others
            11.3.2. Therapeutics 
                     11.3.2.1. Antisense Oligonucleotides
                     11.3.2.2. Nucleic Acid Aptamers
            11.3.3. Diagnostics
     11.4. Market Value Forecast by End User, 2015–2025
            11.4.1. Biotechnology & Pharmaceutical Companies 
            11.4.2. Research Institutes  
            11.4.3. Diagnostic Laboratories 
     11.5. Market Value Forecast by Country, 2015–2025
            11.5.1. China
            11.5.2. India
            11.5.3. Japan
            11.5.4. Australia & New Zealand
            11.5.5. Rest of Asia Pacific 
     11.6. Market Attractiveness Analysis 
            11.6.1. By Product Type 
            11.6.2. By Application 
            11.6.3. By End User 
            11.6.4. By Country

12. Latin America Oligonucleotide Synthesis Market Analysis and Forecast
     12.1. Introduction
            12.1.1. Key Findings
            12.1.2. Key Trends
     12.2. Market Value Forecast by Product Type, 2015–2025
            12.2.1. Reagents & Consumables
            12.2.2. Equipment
            12.2.3. Synthesized oligonucleotides
                     12.2.3.1. DNA Oligonucleotides  
                     12.2.3.2. RNA Oligonucleotides 
                     12.2.3.3. Others
     12.3. Market Value Forecast by Application, 2015–2025
            12.3.1. Research 
                     12.3.1.1. Polymerase Chain Reaction 
                     12.3.1.2. Next Generation Sequencing 
                     12.3.1.3. Others
            12.3.2. Therapeutics 
                     12.3.2.1. Antisense Oligonucleotides
                     12.3.2.2. Nucleic Acid Aptamers
            12.3.3. Diagnostics
     12.4. Market Value Forecast by End User, 2015–2025
            12.4.1. Biotechnology & Pharmaceutical Companies
            12.4.2. Research Institutes  
            12.4.3. Diagnostic Laboratories 
     12.5. Market Value Forecast by Country, 2015–2025
            12.5.1. Brazil 
            12.5.2. Mexico
            12.5.3. Rest of Latin America 
     12.6. Market Attractiveness Analysis 
            12.6.1. By Product Type 
            12.6.2. By Application 
            12.6.3. By End User 
            12.6.4. By Country

13. Middle East & Africa Oligonucleotide Synthesis Market Analysis and Forecast
     13.1. Introduction
            13.1.1. Key Findings
            13.1.3. Key Trends
     13.2. Market Value Forecast by Product Type, 2015–2025
            13.2.1. Reagents & Consumables
            13.2.2. Equipment
            13.2.3. Synthesized oligonucleotides
                     13.2.3.1. DNA Oligonucleotides  
                     13.2.3.2. RNA Oligonucleotides 
                     13.2.3.3. Others
     13.3. Market Value Forecast by Application, 2015–2025
            13.3.1. Research 
                     13.3.1.1. Polymerase Chain Reaction 
                     13.3.1.2. Next Generation Sequencing 
                     13.3.1.3. Others
            13.3.2. Therapeutics 
                     13.3.2.1. Antisense Oligonucleotides
                     13.3.2.2. Nucleic Acid Aptamers
            13.3.3. Diagnostics
     13.4. Market Value Forecast by End User, 2015–2025
            13.4.1. Biotechnology & Pharmaceutical Companies 
            13.4.2. Research Institutes  
            13.4.3. Diagnostic Laboratories 
     13.5. Market Value Forecast by Country, 2015–2025
            13.5.1. Saudi Arabia
            13.5.2. South Africa
            13.5.3. UAE
            13.5.4. Rest of Middle East & Africa
     13.6. Market Attractiveness Analysis 
            13.6.1. By Product Type 
            13.6.2. By Application 
            13.6.3. By End User 
            13.6.4. By Country

14. Competition Landscape
     14.1. Market Player – Competition Matrix (By Tier and Size of companies)
     14.2. Market Share Analysis by Company (2016)
     14.3. Company Profiles (Details – Overview, Financials, Recent Developments, Strategy)
            14.3.1. GE Healthcare
                     14.3.1.1. Financial Overview
                     14.3.1.2. Product Portfolio
                     14.3.1.3. SWOT Analysis
                     14.3.1.4. Strategic Overview
            14.3.2. Thermo Fisher Scientific 
                     14.3.2.1. Financial Overview
                     14.3.2.2. Product Portfolio
                     14.3.2.3. SWOT Analysis
                     14.3.2.4. Strategic Overview
            14.3.3. Agilent Technologies, Inc. 
                     14.3.3.1. Financial Overview
                     14.3.3.2. Product Portfolio
                     14.3.3.3. SWOT Analysis
                     14.3.3.4. Strategic Overview
            14.3.4. Merck KGaA 
                     14.3.4.1. Financial Overview
                     14.3.4.2. Product Portfolio
                     14.3.4.3. SWOT Analysis
                     14.3.4.4. Strategic Overview
            14.3.5. Integrated DNA Technologies, Inc.
                     14.3.5.1. Financial Overview
                     14.3.5.2. Product Portfolio
                     14.3.5.3. SWOT Analysis
                     14.3.5.4. Strategic Overview
            14.3.6. Kaneka Eurogentec S.A. (Kaneka Corporation) 
                     14.3.6.1. Financial Overview
                     14.3.6.2. Product Portfolio
                     14.3.6.3. SWOT Analysis
                     14.3.6.4. Strategic Overview
            14.3.7. TriLink BioTechnologies,LLC  (Maravai Life Sciences) 
                     14.3.7.1. Financial Overview
                     14.3.7.2. Product Portfolio
                     14.3.7.3. SWOT Analysis
                     14.3.7.4. Strategic Overview
            14.3.8. BioAutomation
                     14.3.8.1. Financial Overview
                     14.3.8.2. Product Portfolio
                     14.3.8.3. SWOT Analysis
                     14.3.8.4. Strategic Overview
            14.3.9. ATDBio Ltd.
                     14.3.9.1. Financial Overview
                     14.3.9.2. Product Portfolio
                     14.3.9.3. SWOT Analysis
                     14.3.9.4. Strategic Overview
            14.3.10. Gene Design, Inc. 
                     14.3.10.1. Financial Overview
                     14.3.10.2. Product Portfolio
                     14.3.10.3. SWOT Analysis
                     14.3.10.4. Strategic Overview
            14.3.11. Eurofins Genomics
                     14.3.11.1. Financial Overview
                     14.3.11.2. Product Portfolio
                     14.3.11.3. SWOT Analysis
                     14.3.11.4. Strategic Overview

List of Figures

Figure 01: Global Oligonucleotide Synthesis Market Size (US$ Mn) Forecast, 2015–2025
Figure 02: Global oligonucleotide Synthesis Market Value Share, by Product Type (2016)
Figure 03: Global oligonucleotide Synthesis Market Value Share, by Application (2016)
Figure 04: Global oligonucleotide Synthesis Market Value Share, by End User (2016)
Figure 05: Global oligonucleotide Synthesis Market Value Share, by Region (2016)
Figure 06: Global Oligonucleotide Synthesis Market Value Share, by Product Type, 2017 and 2025
Figure 07: Global Oligonucleotide Synthesis Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Reagents & Consumables, 2015–2025
Figure 08: Global Oligonucleotide Synthesis Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Equipment, 2015–2025
Figure 09: Global Oligonucleotide Synthesis Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Synthesized Oligonucleotides, 2015–2025
Figure 10: Global Oligonucleotide Synthesis Market Attractiveness, by Product Type
Figure 11: Global Oligonucleotide Synthesis Market Value Share, by Application, 2017 and 2025
Figure 12: Global Oligonucleotide Synthesis Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Research, 2015–2025
Figure 13: Global Oligonucleotide Synthesis Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Therapeutics, 2015–2025
Figure 14: Global Oligonucleotide Synthesis Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Diagnostics, 2015–2025
Figure 15: Global Oligonucleotide Synthesis Market Attractiveness, by Application 
Figure 16: Global Oligonucleotide Synthesis Market Value Share, by End-user, 2017 and 2025
Figure 17: Global Oligonucleotide Synthesis Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Biotechnology & Pharmaceutical Companies, 2015–2025
Figure 18: Global Oligonucleotide Synthesis Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Research Institutes, 2015–2025
Figure 19: Global Oligonucleotide Synthesis Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Diagnostic Laboratories, 2015–2025
Figure 20: Global Oligonucleotide Synthesis Market Attractiveness, by End-user 
Figure 21: Global Oligonucleotide Synthesis Market Value Share, by Region, 2017 and 2025 
Figure 22: Global Oligonucleotide Synthesis Market Attractiveness, by Region, 2017–2025
Figure 23: North America Oligonucleotide Synthesis Market Size (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2015–2025
Figure 24: North America Oligonucleotide Synthesis Market Value Share Analysis, by Country, 2017 and 2025
Figure 25: North America Oligonucleotide Synthesis Market Attractiveness, by Country, 2017–2025
Figure 26: North America Oligonucleotide Synthesis Market Value Share, by Product Type, 2017 and 2025
Figure 27: North America Oligonucleotide Synthesis Market Attractiveness, by Product Type, 2017–2025
Figure 28: North America Oligonucleotide Synthesis Market Value Share, by Application, 2017 and 2025
Figure 29: North America Oligonucleotide Synthesis Market Attractiveness, by Application, 2017–2025
Figure 30: North America Oligonucleotide Synthesis Market Value Share, by End-user, 2017 and 2025
Figure 31: North America Oligonucleotide Synthesis Market Attractiveness, by End-user, 2017–2025
Figure 32: Europe Oligonucleotide Synthesis Market Size (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2015–2025
Figure 33: Europe Oligonucleotide Synthesis Market Value Share Analysis, by Country, 2017 and 2025
Figure 34: Europe Oligonucleotide Synthesis Market Attractiveness, by Country, 2017–2025
Figure 35: Europe Oligonucleotide Synthesis Market Value Share, by Product Type, 2017 and 2025
Figure 36: Europe Oligonucleotide Synthesis Market Attractiveness, by Product Type, 2017–2025
Figure 37: Europe Oligonucleotide Synthesis Market Value Share, by Application, 2017 and 2025
Figure 38: Europe Oligonucleotide Synthesis Market Attractiveness, by Application, 2017–2025
Figure 39: Europe Oligonucleotide Synthesis Market Value Share, by End-user, 2017 and 2025
Figure 40: Europe Oligonucleotide Synthesis Market Attractiveness, by End-user, 2017–2025
Figure 41: Asia Pacific Oligonucleotide Synthesis Market Size (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2015–2025
Figure 42: Asia Pacific Oligonucleotide Synthesis Market Value Share Analysis, by Country, 2017 and 2025
Figure 43: Asia Pacific Oligonucleotide Synthesis Market Attractiveness, by Country, 2017–2025
Figure 44: Asia Pacific Oligonucleotide Synthesis Market Value Share, by Product Type, 2017 and 2025
Figure 45: Asia Pacific Oligonucleotide Synthesis Market Attractiveness, by Product Type, 2017–2025
Figure 46: Asia Pacific Oligonucleotide Synthesis Market Value Share, by Application, 2017 and 2025
Figure 47: Asia Pacific Oligonucleotide Synthesis Market Attractiveness, by Application, 2017–2025
Figure 48: Asia Pacific Oligonucleotide Synthesis Market Value Share, by End-user, 2017 and 2025
Figure 49: Asia Pacific Oligonucleotide Synthesis Market Attractiveness, by End-user, 2017–2025
Figure 50: Latin America Oligonucleotide Synthesis Market Size (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2015–2025
Figure 51: Latin America Oligonucleotide Synthesis Market Value Share Analysis, by Country, 2017 and 2025
Figure 52: Latin America Oligonucleotide Synthesis Market Attractiveness, by Country, 2017–2025
Figure 53: Latin America Oligonucleotide Synthesis Market Value Share, by Product Type, 2017 and 2025
Figure 54: Latin America Oligonucleotide Synthesis Market Attractiveness, by Product Type, 2017–2025
Figure 55: Latin America Oligonucleotide Synthesis Market Value Share, by Application, 2017 and 2025
Figure 56: Latin America Oligonucleotide Synthesis Market Attractiveness, by Application, 2017–2025
Figure 57: Latin America Oligonucleotide Synthesis Market Value Share, by End-user, 2017 and 2025
Figure 58: Latin America Oligonucleotide Synthesis Market Attractiveness, by End-user, 2017–2025
Figure 59: Middle East & Africa Oligonucleotide Synthesis Market Size (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2015–2025
Figure 60: Middle East & Africa Oligonucleotide Synthesis Market Value Share Analysis, by Country, 2017 and 2025
Figure 61: Middle East & Africa Oligonucleotide Synthesis Market Attractiveness, by Country, 2017–2025
Figure 62: Middle East & Africa Oligonucleotide Synthesis Market Value Share, by Product Type, 2017 and 2025
Figure 63: Middle East & Africa Oligonucleotide Synthesis Market Attractiveness, by Product Type, 2017–2025
Figure 64: Middle East & Africa Oligonucleotide Synthesis Market Value Share, by Application, 2017 and 2025
Figure 65: Middle East & Africa Oligonucleotide Synthesis Market Attractiveness, by Application, 2017–2025
Figure 66: Middle East & Africa Oligonucleotide Synthesis Market Value Share, by End-user, 2017 and 2025
Figure 67: Middle East & Africa Oligonucleotide Synthesis Market Attractiveness, by End-user, 2017–2025
Figure 68: Global Oligonucleotide Synthesis Market Share, by Company, 2016

List of Tables

Table 01: Global Oligonucleotide Synthesis Market Size (US$ Mn) Forecast, by Product Type, 2015–2025
Table 02: Global Oligonucleotide Synthesis Market Size (US$ Mn) Forecast, by Synthesized Oligonucleotide, 2015–2025
Table 03: Global Oligonucleotide Synthesis Market Size (US$ Mn) Forecast, by Application, 2015–2025
Table 04: Global Oligonucleotide Synthesis Market Size (US$ Mn) Forecast, by Research, 2015–2025
Table 05: Global Oligonucleotide Synthesis Market Size (US$ Mn) Forecast, by Therapeutic, 2015–2025
Table 06: Global Oligonucleotide Synthesis Market Size (US$ Mn) Forecast, by End-user, 2015–2025
Table 07: Global Oligonucleotide Synthesis Market Size (US$ Mn) Forecast, by Region, 2015–2025
Table 08: North America Oligonucleotide Synthesis Market Size (US$ Mn) Forecast, by Country, 2015–2025
Table 09: North America Oligonucleotide Synthesis Market Size (US$ Mn) Forecast, by Product Type, 2015–2025
Table 10: North America Oligonucleotide Synthesis Market Size (US$ Mn) Forecast, by Synthesized Oligonucleotide, 2015–2025
Table 11: North America Oligonucleotide Synthesis Market Size (US$ Mn) Forecast, by Application, 2015–2025
Table 12: North America Oligonucleotide Synthesis Market Size (US$ Mn) Forecast, by Research, 2015–2025
Table 13: North America Oligonucleotide Synthesis Market Size (US$ Mn) Forecast, by Therapeutic, 2015–2025
Table 14: North America Oligonucleotide Synthesis Market Size (US$ Mn) Forecast, by End-user, 2015–2025
Table 15: Europe Oligonucleotide Synthesis Market Size (US$ Mn) Forecast, by Country, 2015–2025
Table 16: Europe Oligonucleotide Synthesis Market Size (US$ Mn) Forecast, by Product Type, 2015–2025
Table 17: Europe Oligonucleotide Synthesis Market Size (US$ Mn) Forecast, by Synthesized Oligonucleotide, 2015–2025
Table 18: Europe Oligonucleotide Synthesis Market Size (US$ Mn) Forecast, by Application, 2015–2025
Table 19: Europe Oligonucleotide Synthesis Market Size (US$ Mn) Forecast, by Research, 2015–2025
Table 20: Europe Oligonucleotide Synthesis Market Size (US$ Mn) Forecast, by Therapeutic, 2015–2025
Table 21: Europe Oligonucleotide Synthesis Market Size (US$ Mn) Forecast, by End-user, 2015–2025
Table 22: Asia Pacific Oligonucleotide Synthesis Market Size (US$ Mn) Forecast, by Country, 2015–2025
Table 23: Asia Pacific Oligonucleotide Synthesis Market Size (US$ Mn) Forecast, by Product Type, 2015–2025
Table 24: Asia Pacific Oligonucleotide Synthesis Market Size (US$ Mn) Forecast, by Synthesized Oligonucleotide, 2015–2025
Table 25: Asia Pacific Oligonucleotide Synthesis Market Size (US$ Mn) Forecast, by Application, 2015–2025
Table 26: Asia Pacific Oligonucleotide Synthesis Market Size (US$ Mn) Forecast, by Research, 2015–2025
Table 27: Asia Pacific Oligonucleotide Synthesis Market Size (US$ Mn) Forecast, by Therapeutic, 2015–2025
Table 28: Asia Pacific Oligonucleotide Synthesis Market Size (US$ Mn) Forecast, by End-user, 2015–2025
Table 29: Latin America Oligonucleotide Synthesis Market Size (US$ Mn) Forecast, by Country, 2015–2025
Table 30: Latin America Oligonucleotide Synthesis Market Size (US$ Mn) Forecast, by Product Type, 2015–2025
Table 31: Latin America Oligonucleotide Synthesis Market Size (US$ Mn) Forecast, by Synthesized Oligonucleotide, 2015–2025
Table 32: Latin America Oligonucleotide Synthesis Market Size (US$ Mn) Forecast, by Application, 2015–2025
Table 33: Latin America Oligonucleotide Synthesis Market Size (US$ Mn) Forecast, by Research, 2015–2025
Table 34: Latin America Oligonucleotide Synthesis Market Size (US$ Mn) Forecast, by Therapeutic, 2015–2025
Table 35: Latin America Oligonucleotide Synthesis Market Size (US$ Mn) Forecast, by End-user, 2015–2025
Table 36: Middle East & Africa Oligonucleotide Synthesis Market Size (US$ Mn) Forecast, by Country, 2015–2025
Table 37: Middle East & Africa Oligonucleotide Synthesis Market Size (US$ Mn) Forecast, by Product Type, 2015–2025
Table 38: Middle East & Africa Oligonucleotide Synthesis Market Size (US$ Mn) Forecast, by Synthesized Oligonucleotide, 2015–2025
Table 39: Middle East & Africa Oligonucleotide Synthesis Market Size (US$ Mn) Forecast, by Application, 2015–2025
Table 40: Middle East & Africa Oligonucleotide Synthesis Market Size (US$ Mn) Forecast, by Research, 2015–2025
Table 41: Middle East & Africa Oligonucleotide Synthesis Market Size (US$ Mn) Forecast, by Therapeutic, 2015–2025
Table 42: Middle East & Africa Oligonucleotide Synthesis Market Size (US$ Mn) Forecast, by End-user, 2015–2025


 
 
Back To Top